BAYZF - Bayer AG Still Dirt-Cheap Investors Are Getting Its Pharma Business For 'Free'
2023-05-02 00:00:00 ET
Summary
- Bayer stock is a textbook example of investing in a wonderful company at a fair price with an estimated upside potential between 30% - 120%.
- The group is suffering from a conglomerate discount and investors are basically getting the Bayer pharma business almost for free.
- The stock is up 20% since the beginning of the year, but trading sideways since February. Investors still have time to hop on the Bayer train.
- Our conservative scenario estimates a fair stock price north of €78.00 (upside of at least 31% on the April closing price of €59.76).
For further details see:
Bayer AG Still Dirt-Cheap, Investors Are Getting Its Pharma Business For 'Free'